Status:
COMPLETED
Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
Assessment of efficacy of vardenafil in subjects with erectile dysfunction and diabetes, hypertension or hyperlipidemia
Eligibility Criteria
Inclusion
- Age: 18 years and older- Males with erectile dysfunction- Stable heterosexual relationship- Medical history / diagnosis of diabetes mellitus and/or hypertension and/or hyperlipidemia
Exclusion
- Primary hypoactive sexual desire- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months- Nitrate use- Other exclusion criteria apply according to Summary of Product Characteristics
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT00668109
Start Date
December 1 2003
End Date
June 1 2004
Last Update
December 23 2014
Active Locations (74)
Enter a location and click search to find clinical trials sorted by distance.
1
Bruxelles - Brussel, Belgium, 1070
2
Bruxelles - Brussel, Belgium, 1200
3
Edegem, Belgium, 2650
4
Roeselare, Belgium, 8800